🇺🇸 6-week olanzapine double blind treatment in United States

6-week olanzapine double blind treatment (6-week olanzapine double blind treatment) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

6-week olanzapine double blind treatment in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 6-week olanzapine double blind treatment approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 6-week olanzapine double blind treatment in United States?

Rene Kahn is the originator. The local marketing authorisation holder may differ — check the official source linked above.